Insider Monkey analyzed the top biotech hedge funds and their stock picks, focusing on Apellis Pharmaceuticals, Inc. (NASDAQ:APLS). Biotech stocks are risky due to clinical trials' impact on stock returns, with average ROI for R&D at 4.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing